Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway. ccm. 2022;6(4):416-423. Accessed September 18, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16285